Dose of LHRH Analog and Growth Velocity Influence Predicted Final Height in Girls with Central Precocious Puberty
暂无分享,去创建一个
K. Tachibana | K. Fujieda | Toshiaki Tanaka | N. Matsuo | K. Ohyama | H. Niimi | I. Hibi | M. Satoh
[1] E. Simpson,et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.
[2] F. Conte,et al. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. , 1995, The Journal of clinical endocrinology and metabolism.
[3] K. Korach,et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.
[4] M. Murata. Japanese Specific Bone Age Standard on the TW2 , 1993 .
[5] S. Hill,et al. Adult height in precocious puberty after long-term treatment with deslorelin. , 1991, The Journal of clinical endocrinology and metabolism.
[6] Z. Laron,et al. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy. , 1990, Hormone research.
[7] M. Ranke,et al. The effects of cyproterone acetate on statural growth in children with precocious puberty. , 1987, Acta Endocrinologica.
[8] N. Stahnke,et al. EFFECT OF CYPROTERONE ACETATE (CA) ON GROWTH AND ENDOCRINE FUNCTION IN PRECOCIOUS PUBERTY , 1979, Acta paediatrica Scandinavica. Supplement.